ATRenew (RERE) Executive President discloses extensive low-priced option grants
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
ATRenew Inc. Executive President Wang Yongliang filed an initial ownership report detailing multiple stock option awards on Class A ordinary shares. The options generally carry a $0.1000 exercise price and expire between 2029 and 2035. One grant covers 182,605 shares awarded on January 1, 2022, vesting in equal 1/4 installments each January 1 over four years, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
29 transactions reported
Mixed
29 txns
Insider
Wang Yongliang
Role
Executive President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Options (Right to Buy) — 3,189 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What does the ATRenew (RERE) Form 3 filing by Wang Yongliang show?
The Form 3 shows Executive President Wang Yongliang’s existing stock option holdings in ATRenew. It details multiple options on Class A ordinary shares with a $0.1000 exercise price and expirations stretching from 2029 through 2035, without reporting any new buy or sell transactions.
What are the key terms of Wang Yongliang’s largest ATRenew stock option grant?
A highlighted grant covers 182,605 Class A ordinary shares, awarded on January 1, 2022. These options vest in four equal 1/4 installments each January 1 over the next four years, subject to his continued service, and carry an exercise price of $0.1000 per share.
Does the ATRenew (RERE) Form 3 indicate insider buying or selling activity?
The Form 3 reflects holdings only and does not report explicit buy or sell transactions. It lists existing options with a $0.1000 exercise price and various expiration dates, serving as an initial statement of beneficial ownership rather than a record of recent trades.
What exercise price is disclosed for Wang Yongliang’s ATRenew stock options?
All listed options for Executive President Wang Yongliang show a conversion or exercise price of $0.1000 per Class A ordinary share. This price applies across numerous grants that expire between 2029 and 2035, according to the filing’s transaction and derivative summaries.
How do Wang Yongliang’s ATRenew options vest according to the Form 3 footnote?
For the 182,605-share grant dated January 1, 2022, the options vest in equal installments of one quarter of the total on each January 1 over the following four years. Vesting is conditioned on his continued service through each applicable vesting date.